BSE filing, NSE: NOCIL. Summary written from the filing by ALFA Finder's alert engine.
NOCIL Ltd: key numbers
- Share price
- ₹146.90
- Market cap
- ₹2,454 Cr
- Revenue (annual)
- ₹1,303 Cr
- Net profit (annual)
- ₹55.63 Cr
- P/E (TTM)
- 37.1×Sector 34.5×
- Promoter holding
- 33.76%+0.00% QoQ
- FII holding
- 5.29%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from NOCIL Ltd
All →NOCIL Board Meeting Date
NOCIL Limited's board will meet on October 29, 2026, to approve un-audited financial results for the quarter ended September 30, 2026. This is a prior intimation of a future board meeting.
NOCIL Employee Stock Options
NOCIL Limited granted 1,04,960 Performance Restricted Stock Units (PRSUs) to eligible employees under its Long Term Incentive Plan 2024.
NOCIL Price Movement Clarification
NOCIL confirmed no undisclosed price-sensitive information to explain a spurt in trading volume. The company affirmed ongoing compliance with SEBI LODR Regulations.
NOCIL Other Announcement
NOCIL Limited has appointed Deloitte Haskins & Sells Chartered Accountants LLP as its statutory auditor for a five-year term, effective from the upcoming 65th AGM.
NOCIL Earnings Call Transcript: Key Takeaways
NOCIL started FY27 with 20% revenue growth, but temporary utility and logistical constraints hampered volumes. Management remains optimistic, banking on anti-dumping duties and new TDQ plant ramp-ups to offset input cost pressures.
NOCIL Results Update
NOCIL reported Q1FY27 net profit of ₹28 crore and revenue of ₹403 crore. The company also announced an additional ₹130 crore capital expenditure for Dahej capacity.
- Value
- ₹403.0 Cr
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.